Constitutive or abnormal activation of NF-κB is frequently observed in various solid tumors, such as lung cancer [49], ovarian cancer [50], prostate cancer [51], gastric carcinoma [52], colorectal cancer [53], and breast cancer [54]. This evidence concerns the gene NFKB1 and prostate cancer.